Literature DB >> 22413858

Effects of point substitutions on the structure of toxic Alzheimer's β-amyloid channels: atomic force microscopy and molecular dynamics simulations.

Laura Connelly1, Hyunbum Jang, Fernando Teran Arce, Srinivasan Ramachandran, Bruce L Kagan, Ruth Nussinov, Ratnesh Lal.   

Abstract

Alzheimer's disease (AD) is a misfolded protein disease characterized by the accumulation of β-amyloid (Aβ) peptide as senile plaques, progressive neurodegeneration, and memory loss. Recent evidence suggests that AD pathology is linked to the destabilization of cellular ionic homeostasis mediated by toxic pores made of Aβ peptides. Understanding the exact nature by which these pores conduct electrical and molecular signals could aid in identifying potential therapeutic targets for the prevention and treatment of AD. Here using atomic force microscopy (AFM) and molecular dynamics (MD) simulations, we compared the imaged pore structures with models to predict channel conformations as a function of amino acid sequence. Site-specific amino acid (AA) substitutions in the wild-type Aβ(1-42) peptide yield information regarding the location and significance of individual AA residues to its characteristic structure-activity relationship. We selected two AAs that our MD simulation predicted to inhibit or permit pore conductance. The substitution of Phe19 with Pro has previously been shown to eliminate conductance in the planar lipid bilayer system. Our MD simulations predict a channel-like shape with a collapsed pore, which is supported by the AFM channel images. We suggest that proline, a known β-sheet breaker, creates a kink in the center of the pore and prevents conductance via blockage. This residue may be a viable target for drug development studies aiming to inhibit Aβ from inducing ionic destabilization toxicity. The substitution of Phe20 with Cys exhibits pore structures indistinguishable from the wild type in AFM images. MD simulations predict site 20 to face the solvated pore. Overall, the mutations support the previously predicted β-sheet-based channel structure.
© 2012 American Chemical Society

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22413858      PMCID: PMC7512688          DOI: 10.1021/bi300257e

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  42 in total

1.  Misfolded amyloid ion channels present mobile beta-sheet subunits in contrast to conventional ion channels.

Authors:  Hyunbum Jang; Fernando Teran Arce; Ricardo Capone; Srinivasan Ramachandran; Ratnesh Lal; Ruth Nussinov
Journal:  Biophys J       Date:  2009-12-02       Impact factor: 4.033

2.  Structural changes of region 1-16 of the Alzheimer disease amyloid beta-peptide upon zinc binding and in vitro aging.

Authors:  Séverine Zirah; Sergey A Kozin; Alexey K Mazur; Alain Blond; Michel Cheminant; Isabelle Ségalas-Milazzo; Pascale Debey; Sylvie Rebuffat
Journal:  J Biol Chem       Date:  2005-11-21       Impact factor: 5.157

3.  The pore dimensions of gramicidin A.

Authors:  O S Smart; J M Goodfellow; B A Wallace
Journal:  Biophys J       Date:  1993-12       Impact factor: 4.033

4.  Polymorphism of amyloid β peptide in different environments: implications for membrane insertion and pore formation.

Authors:  Fernando Terán Arce; Hyunbum Jang; Srinivasan Ramachandran; Preston B Landon; Ruth Nussinov; Ratnesh Lal
Journal:  Soft Matter       Date:  2011-05-09       Impact factor: 3.679

5.  Atomic force microscopy and MD simulations reveal pore-like structures of all-D-enantiomer of Alzheimer's β-amyloid peptide: relevance to the ion channel mechanism of AD pathology.

Authors:  Laura Connelly; Hyunbum Jang; Fernando Teran Arce; Ricardo Capone; Samuel A Kotler; Srinivasan Ramachandran; Bruce L Kagan; Ruth Nussinov; Ratnesh Lal
Journal:  J Phys Chem B       Date:  2012-01-25       Impact factor: 2.991

6.  Experimental constraints on quaternary structure in Alzheimer's beta-amyloid fibrils.

Authors:  Aneta T Petkova; Wai-Ming Yau; Robert Tycko
Journal:  Biochemistry       Date:  2006-01-17       Impact factor: 3.162

7.  Scanning cysteine mutagenesis analysis of Abeta-(1-40) amyloid fibrils.

Authors:  Shankaramma Shivaprasad; Ronald Wetzel
Journal:  J Biol Chem       Date:  2005-11-01       Impact factor: 5.157

8.  Alzheimer's Abeta peptides containing an isostructural backbone mutation afford distinct aggregate morphologies but analogous cytotoxicity. Evidence for a common low-abundance toxic structure(s)?

Authors:  Jan Bieschke; Sarah J Siegel; Yanwen Fu; Jeffery W Kelly
Journal:  Biochemistry       Date:  2007-12-14       Impact factor: 3.162

9.  Architecture of the Alzheimer's A beta P ion channel pore.

Authors:  N Arispe
Journal:  J Membr Biol       Date:  2004-01-01       Impact factor: 1.843

10.  Purification, ultrastructure, and chemical analysis of Alzheimer disease amyloid plaque core protein.

Authors:  A Roher; D Wolfe; M Palutke; D KuKuruga
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

View more
  25 in total

1.  The higher level of complexity of K-Ras4B activation at the membrane.

Authors:  Hyunbum Jang; Avik Banerjee; Tanmay S Chavan; Shaoyong Lu; Jian Zhang; Vadim Gaponenko; Ruth Nussinov
Journal:  FASEB J       Date:  2015-12-30       Impact factor: 5.191

2.  Microsecond molecular dynamics simulation of Aβ42 and identification of a novel dual inhibitor of Aβ42 aggregation and BACE1 activity.

Authors:  Yuan-yuan Wang; Li Li; Tian-tian Chen; Wu-yan Chen; Ye-chun Xu
Journal:  Acta Pharmacol Sin       Date:  2013-06-17       Impact factor: 6.150

3.  Familial Alzheimer's disease Osaka mutant (ΔE22) β-barrels suggest an explanation for the different Aβ1-40/42 preferred conformational states observed by experiment.

Authors:  Hyunbum Jang; Fernando Teran Arce; Srinivasan Ramachandran; Bruce L Kagan; Ratnesh Lal; Ruth Nussinov
Journal:  J Phys Chem B       Date:  2013-09-13       Impact factor: 2.991

4.  Reduced Lipid Bilayer Thickness Regulates the Aggregation and Cytotoxicity of Amyloid-β.

Authors:  Kyle J Korshavn; Cristina Satriano; Yuxi Lin; Rongchun Zhang; Mark Dulchavsky; Anirban Bhunia; Magdalena I Ivanova; Young-Ho Lee; Carmelo La Rosa; Mi Hee Lim; Ayyalusamy Ramamoorthy
Journal:  J Biol Chem       Date:  2017-02-01       Impact factor: 5.157

5.  Distinct Membrane Disruption Pathways Are Induced by 40-Residue β-Amyloid Peptides.

Authors:  Dennis A Delgado; Katelynne Doherty; Qinghui Cheng; Hyeongeun Kim; Dawei Xu; He Dong; Christof Grewer; Wei Qiang
Journal:  J Biol Chem       Date:  2016-04-07       Impact factor: 5.157

6.  The membrane axis of Alzheimer's nanomedicine.

Authors:  Yuhuan Li; Huayuan Tang; Nicholas Andrikopoulos; Ibrahim Javed; Luca Cecchetto; Aparna Nandakumar; Aleksandr Kakinen; Thomas P Davis; Feng Ding; Pu Chun Ke
Journal:  Adv Nanobiomed Res       Date:  2020-11-26

Review 7.  Disordered amyloidogenic peptides may insert into the membrane and assemble into common cyclic structural motifs.

Authors:  Hyunbum Jang; Fernando Teran Arce; Srinivasan Ramachandran; Bruce L Kagan; Ratnesh Lal; Ruth Nussinov
Journal:  Chem Soc Rev       Date:  2014-10-07       Impact factor: 54.564

8.  The on-fibrillation-pathway membrane content leakage and off-fibrillation-pathway lipid mixing induced by 40-residue β-amyloid peptides in biologically relevant model liposomes.

Authors:  Qinghui Cheng; Zhi-Wen Hu; Katelynne E Doherty; Yuto J Tobin-Miyaji; Wei Qiang
Journal:  Biochim Biophys Acta Biomembr       Date:  2018-03-13       Impact factor: 3.747

Review 9.  Alzheimer's disease: which type of amyloid-preventing drug agents to employ?

Authors:  Hyunbum Jang; Laura Connelly; Fernando Teran Arce; Srinivasan Ramachandran; Ratnesh Lal; Bruce L Kagan; Ruth Nussinov
Journal:  Phys Chem Chem Phys       Date:  2013-02-28       Impact factor: 3.676

10.  Mechanisms for the Insertion of Toxic, Fibril-like β-Amyloid Oligomers into the Membrane.

Authors:  Hyunbum Jang; Laura Connelly; Fernando Teran Arce; Srinivasan Ramachandran; Bruce L Kagan; Ratnesh Lal; Ruth Nussinov
Journal:  J Chem Theory Comput       Date:  2012-12-05       Impact factor: 6.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.